Four Visual Changes That Can Occur With Eye Lymphoma

What eye lymphoma can affect

Eye lymphoma is a rare type of non-Hodgkin lymphoma that can affect tissues around and inside the eye. A picture may show a concerning pattern, but it cannot confirm lymphoma, identify its type, or determine its stage.

Intraocular lymphoma affects structures inside the eye. Doctors divide it by location into vitreoretinal lymphoma, which involves the retina or the vitreous gel, and uveal lymphoma, which involves the iris, ciliary body, or choroid. Intraocular lymphoma may also be primary or secondary. Primary disease begins in the central nervous system or related tissues, while secondary disease spreads to the eye from lymphoma elsewhere in the body.

Orbital lymphoma begins around the eye rather than inside it. Possible starting areas include the lacrimal gland, conjunctiva, or eye muscles. These categories matter because the location and relationship to disease elsewhere in the body affect the evaluation and treatment plan.

Eye inflammation, called uveitis, can occur with intraocular lymphoma. A report published August 18, 2021, described uveitis in 75 percent of cases; that figure measures the cases in that report and does not mean that every case of uveitis is lymphoma.

A large network study cited in a clinical discussion found a median age at diagnosis of approximately 64 years for ocular lymphoma. Median age describes the midpoint of that study group, not an age cutoff and not a way to diagnose the disease.

Know who may have higher risk

People whose immune systems do not work properly are at risk for primary vitreoretinal lymphoma. Risk is also higher with increasing age and immune-suppressing medicines after an organ transplant. These factors can change the level of concern, but they do not establish a diagnosis.

For conjunctival lymphoma, reported risk factors include chronic exposure to some solvents or reagents and chronic autoimmune conditions. The role of chronic antigen stimulation remains controversial.

Chronic antigen stimulation has been proposed as a possible link, but that relationship remains controversial.

Your symptoms still deserve attention even when you have no known risk factor. Eye lymphoma can resemble more common conditions, so the appearance or duration of a change matters more than trying to match yourself to a risk list.

Four visual categories of eye lymphoma

This text guide organizes reported eye findings into four visual categories. Use each description to understand what a change may show and what it cannot demonstrate. None of these appearances proves lymphoma, its subtype, its stage, or the treatment you would need.

1. Swelling, eyelid drooping, or a bulging eye

This category includes a slowly enlarging lump or swelling around the eye. It may also include a drooping eyelid or an eye that appears pushed forward. Orbital lymphoma can be associated with double vision, eye misalignment, or reduced vision.

A single case report described an 87-year-old man with sudden swelling of one eyelid and vision loss in that eye. A case report shows one person’s presentation. It does not establish how eye lymphoma usually begins or how a new swelling will develop.

2. A salmon-pink patch on the eye’s surface

A conjunctival lymphoma may cause a painless salmon-pink or salmon-colored patch on the surface of the eye, often in one eye.
In one reported series, conjunctival disease made up nearly 40% of orbital lymphoma cases. That percentage measures the case mix in that report; it does not mean that nearly 40% of all surface patches are lymphoma. A salmon-colored patch can also look like reactive lymphoid hyperplasia, so its color and shape cannot confirm cancer.

3. Haze, cells, or yellow deposits inside the eye

Vitreoretinal lymphoma may cause haze or cells in the vitreous gel. It may also cause yellow deposits beneath the retina or changes in the retinal pigment layer that create a leopard-spotting pattern. These findings may occur with vitreoretinal lymphoma.

Not everyone with ocular lymphoma has a leopard-spotting pattern. Some changes require specialized examination or imaging to detect. Examination and imaging can help an eye specialist decide what to investigate, but they cannot confirm the diagnosis.

4. Redness, inflammation, floaters, or blurred vision

Some presentations show little that is distinctive. You may have blurred or reduced vision, floaters, redness, swelling, light sensitivity, or eye pain without a clear external mass. Intraocular lymphoma commonly causes blurred vision and floaters, while redness and pain are less common.

Orbital lymphoma represents approximately 1% to 2% of non-Hodgkin lymphomas in one cited discussion. The same discussion reported that more than half of affected patients had systemic symptoms such as fever, night sweats, or weight loss. These figures describe the population discussed in that report, not the meaning of a symptom in your case.

Another cited report described orbital lymphoma as approximately 10% of orbital neoplasms and 2% of lymphoid and extranodal lymphomas. Those percentages use different comparison groups, so they should not be combined or treated as a personal risk estimate.

Understand why similar changes have other causes

Eye lymphoma symptoms overlap with many other eye problems. Possible symptoms include blurry or reduced vision, redness or swelling, sensitivity to light, floaters, and eye pain. The same symptoms can occur with inflammation, infection, or other conditions.

Ocular lymphoma can look like uveitis, which is inflammation inside the eye. This resemblance can delay diagnosis because the early appearance may seem consistent with a more common inflammatory problem. A temporary improvement after treatment does not by itself establish the cause.

A salmon-colored patch is not proof of lymphoma. Reactive lymphoid hyperplasia can look just like conjunctival lymphoma, and doctors distinguish them with a biopsy and laboratory examination.

Infections and inflammatory diseases, including sarcoidosis and Behcet’s disease, can also resemble intraocular lymphoma. Other cancers may create similar findings. For that reason, a picture cannot tell you whether a change is benign, infectious, inflammatory, or malignant.

See how doctors investigate suspected eye lymphoma

Eye lymphoma evaluation starts with your symptoms and medical history. An ophthalmologist may check your vision and eye movements, examine the outside of the eye, and look inside the eye with a lighted instrument.

The evaluation may then include photographs or scans. Fluorescein angiography, fundus autofluorescence, and optical coherence tomography can help identify suspicious changes. These tests support the examination, but they cannot confirm ocular lymphoma.

Confirmation requires testing cells or tissue. The test depends on where the suspected lymphoma is located:

• A suspected conjunctival lymphoma requires a biopsy of the conjunctiva followed by laboratory examination of the tissue.
• A suspected intraocular lymphoma may require a vitrectomy, which collects fluid or tissue from inside the eye.
• Laboratory testing may examine the cells, proteins, and genetic material in a sample.
• Testing can include cytology, immunocytochemistry, flow cytometry, interleukin measurements, and polymerase chain reaction testing for clonality.

Using several laboratory tests can improve the chance of finding the diagnosis. Normal chest X-ray results, spinal-fluid testing, brain MRI, or whole-body PET scans do not by themselves rule out intraocular lymphoma.

A clinical summary reports the MYD88 L265P mutation in about 80 percent of ocular lymphoma cases; PCR testing may detect it. That figure describes a reported genetic finding in ocular lymphoma cases, not something that can be identified by looking at a photograph.

Primary intraocular lymphoma is linked to primary central nervous system lymphoma. One review reports that approximately one-third of patients have central nervous system lymphoma at presentation, while 42–92% develop it within a mean of 8–29 months. Another summary reports that about 90 percent of people with intraocular lymphoma develop central nervous system involvement within approximately two years.

These estimates come from different reports and time ranges. They are not a prediction for you. Doctors use the examination, laboratory results, and staging tests to determine whether disease is present elsewhere.

Learn why treatment depends on the diagnosis

Eye lymphoma treatment is chosen after the form, location, and extent of disease are confirmed. The assessment also considers whether the lymphoma is primary or secondary and whether it involves one eye, both eyes, the central nervous system, or other parts of the body.

Possible treatments include medicine injected into the eye, chemotherapy through the body, radiation, immune-based treatment, or a combination. Different forms have different treatment considerations, so a picture cannot tell you which option applies.

For primary vitreoretinal lymphoma, treatment depends on whether one eye, both eyes, or the central nervous system is involved. Options may include medicine injected into the eye, systemic medicine, and, in selected cases, 30 to 35 Gy of external-beam radiation.

When retinal or vitreous lymphoma is part of central nervous system lymphoma, doctors use systemic combination chemotherapy. Staging may include a lumbar puncture and brain imaging before treatment. The treatment plan requires coordination between eye specialists and oncology specialists.

Orbital lymphoma is often low grade. For stage IE disease, a selected review says radiotherapy alone can usually be used in the described setting, including 30 Gy in 15 fractions over 3 weeks. That schedule applies to the setting described in the review, not to every orbital mass.

Reported treatment options for conjunctival lymphoma include radiation, immune-based treatment, chemotherapy, and antibiotics. Secondary intraocular lymphoma most often affects the choroid. When systemic lymphoma involves the eye, staging and close coordination with an experienced oncologist are critical.

Know when to arrange an eye evaluation

Concerning eye or eyelid changes deserve qualified eye evaluation, especially when they are new, persistent, or worsening. Arrange an evaluation for:

• Blurred, reduced, or lost vision
• New floaters
• Persistent redness or swelling
• Light sensitivity or eye pain
• A slowly enlarging lump around the eye
• Eyelid drooping or swelling
• A bulging eye or double vision
• A painless salmon-colored patch on the eye’s surface
• Unexplained inflammation that does not settle

These signs do not prove lymphoma. They indicate that visual comparison alone is not enough to identify the cause.

An incomplete, temporary, or intermittent response to steroids should prompt consideration of intraocular lymphoma rather than ending the evaluation. For suspected vitreoretinal lymphoma, a vitreous sample obtained through pars plana vitrectomy is virtually the only way to confirm the diagnosis.

We request that you do not use our contact form in the case of an ocular emergency. If you are unsure whether a new or worsening eye or vision change needs emergency care, contact a qualified professional or the responsible authority promptly rather than using our contact form. Do not rely on an online image, a normal scan, or a short-lived treatment response to decide that a serious eye change is harmless.

Take the next step for a concerning eye change

If you have an ocular emergency, use emergency care rather than our contact form.

What should I do if an eye lymphoma picture looks like my symptom?

Can eye lymphoma pictures show the stage or type of lymphoma?

No. A picture may show a pattern that needs further evaluation, but it cannot confirm lymphoma, identify its subtype, or determine its stage. Doctors need an eye examination, appropriate imaging, and testing of cells or tissue before they can discuss the diagnosis or treatment plan.

Does a salmon-pink patch on the eye mean lymphoma?

No. A salmon-pink patch can occur with conjunctival lymphoma, but it can also look like reactive lymphoid hyperplasia or another condition. Because appearance alone cannot distinguish these causes, an eye specialist may recommend a conjunctival biopsy and laboratory examination of the tissue.

What tests confirm suspected eye lymphoma?

Confirmation requires testing cells or tissue rather than relying on a photograph or scan. Depending on the location, doctors may use a conjunctival biopsy or vitrectomy to collect an eye sample. Laboratory testing can examine cells, proteins, and genetic material, while staging may include body or brain imaging and spinal-fluid testing.

When should a new eye change be evaluated promptly?

Arrange qualified eye care for new, persistent, or worsening vision loss, floaters, swelling, a bulging eye, double vision, eyelid drooping, a painless surface patch, or unexplained inflammation. Use emergency care for an ocular emergency rather than an online comparison or a clinic contact form, and do not assume a temporary treatment response makes the change harmless.

How is eye lymphoma treatment chosen?

Treatment is chosen after doctors confirm the lymphoma’s form, location, and extent. Options may include medicine injected into the eye, systemic chemotherapy, radiation, immune-based treatment, or combinations. The plan also depends on whether one eye, both eyes, the central nervous system, or other parts of the body are involved.